1-[[1-(8-chloro-6-fluoroquinolin-4-yl)-2-methyl-6-morpholin-4-ylbenzimidazole-4-carboximidoyl]amino]ethylidene-[4-[2-methyl-4-(5-methyl-4H-1,2,4-triazol-3-yl)-6-morpholin-4-ylbenzimidazol-1-yl]quinolin-8-yl]azanium
C48H45ClFN14O2+ — CID 142311471
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[[1-(8-chloro-6-fluoroquinolin-4-yl)-2-methyl-6-morpholin-4-ylbenzimidazole-4-carboximidoyl]amino]ethylidene-[4-[2-methyl-4-(5-methyl-4H-1,2,4-triazol-3-yl)-6-morpholin-4-ylbenzimidazol-1-yl]quinolin-8-yl]azanium
1-[[1-(8-chloro-6-fluoroquinolin-4-yl)-2-methyl-6-morpholin-4-ylbenzimidazole-4-carboximidoyl]amino]ethylidene-[4-[2-methyl-4-(5-methyl-4H-1,2,4-triazol-3-yl)-6-morpholin-4-ylbenzimidazol-1-yl]quinolin-8-yl]azanium (PubChem CID 142311471) has the molecular formula C48H45ClFN14O2+ and a molecular weight of 904.43 g/mol. Its IUPAC name is 1-[[1-(8-chloro-6-fluoroquinolin-4-yl)-2-methyl-6-morpholin-4-ylbenzimidazole-4-carboximidoyl]amino]ethylidene-[4-[2-methyl-4-(5-methyl-4H-1,2,4-triazol-3-yl)-6-morpholin-4-ylbenzimidazol-1-yl]quinolin-8-yl]azanium.
Molecular Properties
| Compound Name | 1-[[1-(8-chloro-6-fluoroquinolin-4-yl)-2-methyl-6-morpholin-4-ylbenzimidazole-4-carboximidoyl]amino]ethylidene-[4-[2-methyl-4-(5-methyl-4H-1,2,4-triazol-3-yl)-6-morpholin-4-ylbenzimidazol-1-yl]quinolin-8-yl]azanium |
|---|---|
| PubChem CID | 142311471 |
| Molecular Formula | C48H45ClFN14O2+ |
| Molecular Weight | 904.43 g/mol |
| Exact Mass | 903.35 |
| IUPAC Name | 1-[[1-(8-chloro-6-fluoroquinolin-4-yl)-2-methyl-6-morpholin-4-ylbenzimidazole-4-carboximidoyl]amino]ethylidene-[4-[2-methyl-4-(5-methyl-4H-1,2,4-triazol-3-yl)-6-morpholin-4-ylbenzimidazol-1-yl]quinolin-8-yl]azanium |
| SMILES | [H]/N=C(\N/C(C)=[NH+]/c1cccc2c(-n3c(C)nc4c(-c5nnc(C)[nH]5)cc(N5CCOCC5)cc43)ccnc12)c1cc(N2CCOCC2)cc2c1nc(C)n2-c1ccnc2c(Cl)cc(F)cc12 |
| InChI | InChI=1S/C48H44ClFN14O2/c1-26(55-47(51)35-22-31(61-12-16-65-17-13-61)24-41-45(35)57-28(3)64(41)40-9-10-52-43-34(40)20-30(50)21-37(43)49)54-38-7-5-6-33-39(8-11-53-44(33)38)63-29(4)58-46-36(48-56-27(2)59-60-48)23-32(25-42(46)63)62-14-18-66-19-15-62/h5-11,20-25H,12-19H2,1-4H3,(H2,51,54,55)(H,56,59,60)/p+1 |
| InChIKey | ZLFOVFVMOSECHO-UHFFFAOYSA-O |
| XLogP | 6.38 |
| TPSA | 177.78 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 66 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 904.43 |
| LogP ≤ 5 | 6.38 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 13 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142311471 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.